Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 2
2004 2
2005 2
2007 1
2008 4
2009 3
2010 4
2011 11
2012 4
2013 5
2014 7
2015 7
2016 5
2017 11
2018 3
2019 7
2020 9
2021 13
2022 8
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Results by year

Filters applied: . Clear all
Page 1
Individualised neoantigen cancer vaccine therapy.
Terai M, Sato T. Terai M, et al. Among authors: sato t. Lancet. 2024 Feb 17;403(10427):590-591. doi: 10.1016/S0140-6736(23)02463-7. Epub 2024 Jan 18. Lancet. 2024. PMID: 38246193 No abstract available.
Liver Transplantation in a Woman with Mahvash Disease.
Robbins J, Halegoua-DeMarzio D, Basu Mallick A, Vijayvergia N, Ganetzky R, Lavu H, Giri VN, Miller J, Maley W, Shah AP, DiMeglio M, Ambelil M, Yu R, Sato T, Lefler DS. Robbins J, et al. Among authors: sato t. N Engl J Med. 2023 Nov 23;389(21):1972-1978. doi: 10.1056/NEJMoa2303226. N Engl J Med. 2023. PMID: 37991855
Co-Targeting FASN and mTOR Suppresses Uveal Melanoma Growth.
Han A, Mukha D, Chua V, Purwin TJ, Tiago M, Modasia B, Baqai U, Aumiller JL, Bechtel N, Hunter E, Danielson M, Terai M, Wedegaertner PB, Sato T, Landreville S, Davies MA, Kurtenbach S, Harbour JW, Schug ZT, Aplin AE. Han A, et al. Among authors: sato t. Cancers (Basel). 2023 Jun 30;15(13):3451. doi: 10.3390/cancers15133451. Cancers (Basel). 2023. PMID: 37444561 Free PMC article.
Improved Uveal Melanoma Copy Number Subtypes Including an Ultra-High-Risk Group.
Lalonde E, Ewens K, Richards-Yutz J, Ebrahimzedeh J, Terai M, Gonsalves CF, Sato T, Shields CL, Ganguly A. Lalonde E, et al. Among authors: sato t. Ophthalmol Sci. 2022 Jan 30;2(2):100121. doi: 10.1016/j.xops.2022.100121. eCollection 2022 Jun. Ophthalmol Sci. 2022. PMID: 36249692 Free PMC article.
Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial.
Carvajal RD, Butler MO, Shoushtari AN, Hassel JC, Ikeguchi A, Hernandez-Aya L, Nathan P, Hamid O, Piulats JM, Rioth M, Johnson DB, Luke JJ, Espinosa E, Leyvraz S, Collins L, Goodall HM, Ranade K, Holland C, Abdullah SE, Sacco JJ, Sato T. Carvajal RD, et al. Among authors: sato t. Nat Med. 2022 Nov;28(11):2364-2373. doi: 10.1038/s41591-022-02015-7. Epub 2022 Oct 13. Nat Med. 2022. PMID: 36229663 Free PMC article. Clinical Trial.
Characterizing metastatic uveal melanoma patients who develop symptomatic brain metastases.
Wei AZ, Uriel M, Porcu A, Manos MP, Mercurio AC, Caplan MM, Hulse L, Seedor RS, Holovatska M, Francis J, Khan SA, McDonnell DE, Bogomolny D, Sato T, Marr BP, Haq R, Orloff M, Shoushtari A, Carvajal RD. Wei AZ, et al. Among authors: sato t. Front Oncol. 2022 Sep 8;12:961517. doi: 10.3389/fonc.2022.961517. eCollection 2022. Front Oncol. 2022. PMID: 36212499 Free PMC article.
Phase IB Study of GITR Agonist Antibody TRX518 Singly and in Combination with Gemcitabine, Pembrolizumab, or Nivolumab in Patients with Advanced Solid Tumors.
Davar D, Zappasodi R, Wang H, Naik GS, Sato T, Bauer T, Bajor D, Rixe O, Newman W, Qi J, Holland A, Wong P, Sifferlen L, Piper D, Sirard CA, Merghoub T, Wolchok JD, Luke JJ. Davar D, et al. Among authors: sato t. Clin Cancer Res. 2022 Sep 15;28(18):3990-4002. doi: 10.1158/1078-0432.CCR-22-0339. Clin Cancer Res. 2022. PMID: 35499569 Free PMC article.
101 results